- -Friday, 04 May 2012 11:53
Consistent with FDA and OHRP guidance on Adverse Event reporting to IRBs, Sterling IRB no longer requires the submission of Adverse Events unless the event is serious, unexpected, and related or possibly related to participation in the research. This change in policy was effective April 13, 2012. The revised Serious Adverse Event Report form is available in the Investigator Forms section of the Sterling IRB website and may be accessed here.